Clinical Research Directory
Browse clinical research sites, groups, and studies.
Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes
Sponsor: IRCCS San Raffaele
Summary
Type 1 Diabetes is an autoimmune disease in which immune cells contribute to the destruction of insulin-producing pancreatic beta cells. This study investigates whether targeting glucose transporter 1 (GLUT1), a transporter involved in immune cell metabolism, may help modulate autoimmune responses associated with Type 1 Diabetes. The study uses previously collected and biobanked peripheral blood mononuclear cells (PBMCs) from individuals with Type 1 Diabetes. No additional visits, blood draws, or study-specific procedures will be performed on human participants.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
84
Start Date
2026-09
Completion Date
2029-09
Last Updated
2026-07-14
Healthy Volunteers
No
Conditions
Locations (1)
IRCCS San Raffaele Scientific Institute
Milan, Italy